WealthTrust-Arizona’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-10
Closed -$3K 673
2018
Q1
$3K Hold
10
﹤0.01% 533
2017
Q4
$3K Hold
10
﹤0.01% 544
2017
Q3
$3K Hold
10
﹤0.01% 543
2017
Q2
$3K Buy
+10
New +$2.64K ﹤0.01% 522
2015
Q3
Sell
-155
Closed -$63K 581
2015
Q2
$63K Buy
155
+139
+869% +$55.8K 0.04% 137
2015
Q1
$7K Hold
16
﹤0.01% 461
2014
Q4
$5K Buy
16
+7
+78% +$2.27K ﹤0.01% 479
2014
Q3
$3K Buy
+9
New +$2.97K ﹤0.01% 527

Other funds holding BIIB

WealthTrust-Arizona's BIIB Position: Q2 2018 in Review

WealthTrust-Arizona sold out of Biogen (BIIB) in Q2 2018, closing a stake of 10 shares — an estimated $3K sold.

WealthTrust-Arizona first reported a position in BIIB in Q3 2014 and held it in 8 quarters. The position peaked at $63K in Q2 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • WealthTrust-Arizona reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • WealthTrust-Arizona sold 10 Biogen shares in Q2 2018, an estimated $3K.
  • WealthTrust-Arizona first reported a position in Biogen in Q3 2014 and held it in 8 quarters.
  • WealthTrust-Arizona's Biogen position peaked at $63K in Q2 2015.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on WealthTrust-Arizona's 13F filing for Q2 2018, filed 17 Jul 2018.